אירועים
אירועים והרצאות בפקולטה למדעי המחשב ע"ש הנרי ומרילין טאוב
יום רביעי, 14.03.2012, 11:30
After decades of research, vaccines against some of the greatest
viral threats are still lacking and antiviral drugs remain few and slow in
coming. These shortcomings point to the need for new approaches that go
beyond traditional virology methods. High-throughput technologies and
computational biology promise to deliver a much-needed boost to the field.
My laboratory is using systems biology and computational approaches to
understand and model integrated views of virus-host interactions, viral
evasion of host defenses, and viral pathogenesis. Much of our work is focused on
viruses responsible for worldwide pandemics, including influenza virus, hepatitis C
virus, and human immunodeficiency virus. As new experimental systems and
technologies continue to come online, such as mouse systems genetics,
metabolomics, lipidomics, and next-generation sequencing, our systems-level
views have expanded to encompass host genetic variation, metabolic pathways,
epigenetics, microRNAs, and long noncoding RNAs. Because this amount of
information is beyond the capacity of human intuition to grasp, mathematical
frameworks and computational models must be constructed. Such models are
necessary to predict how molecular components work together to yield
operational mechanisms and phenotypic outcome. Models also provide predictions
for how to most effectively design new diagnostics, therapeutics, and vaccines.
The combination of high-throughput datasets and computational methods provides
best hope for understanding viral pathogenesis and speeding vaccine and drug
development.
Michael Katze is a Professor of Microbiology at the University of Washington and
Associate Director and Core Staff Scientist at the Washington National Primate
Research Center. He is also Director of the Center for Systems and
Translational Research on Infectious Disease (STRIDE). He has studied
virus-host interactions for more than 30 years and is a world leader in the use
of systems biology approaches, including high-throughput technologies and
computational methods, to understand, define and model virus-host interactions
in a broad range of experimental systems.